Cargando…

Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran

Siderophores secreted by nonfermentative negative bacilli such as Pseudomonas aeruginosa are capable of increasing rates of resistance to carbapenem antibiotics. Furthermore, the resistance of these isolates to antibiotics has been enhanced by producing siderophores, and their frequencies have errat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeqi Nezhad, M., Pordeli, H., Ghasemi, N., Ahani, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004779/
https://www.ncbi.nlm.nih.gov/pubmed/29922475
http://dx.doi.org/10.1016/j.nmni.2018.04.003
_version_ 1783332582294814720
author Sadeqi Nezhad, M.
Pordeli, H.
Ghasemi, N.
Ahani, A.
author_facet Sadeqi Nezhad, M.
Pordeli, H.
Ghasemi, N.
Ahani, A.
author_sort Sadeqi Nezhad, M.
collection PubMed
description Siderophores secreted by nonfermentative negative bacilli such as Pseudomonas aeruginosa are capable of increasing rates of resistance to carbapenem antibiotics. Furthermore, the resistance of these isolates to antibiotics has been enhanced by producing siderophores, and their frequencies have erratic patterns. We studied the outbreak of P. aeruginosa strains and their antibiotic patterns in different clinical samples. In this descriptive cross-sectional study, 100 P. aeruginosa samples were isolated from different clinical specimens at the 5th Azar Hospital, Gorgan, Iran, in 2017. These strains were identified by biochemical tests, and their antibiotic resistance patterns were measured via the disc diffusion method. Next imipenem and EDTA-imipenem (10–30 μg) antibiotics were employed for the detection of siderophores. Amongst 100 P. aeruginosa samples, 31 isolates (31%) were siderophore carriers. The frequency of this enzyme among specimens was as follows: 56.2% in burn wounds, 36.4% in urine, 22.2% in respiratory secretion, 19.4% in blood and 16.7% in wounds (p > 0.05). Moreover, P. aeruginosa isolates producing siderophores had the highest range of resistance to ciprofloxacin (47.6%), gentamicin (46.7%), ceftazidime (34.9%), nalidixic acid (34.3%), amikacin (34.1%) and cefotaxime (31.6%). The prevalence of siderophore producers, and especially their antibiotic patterns have no specific algorithms; in addition, an antibiogram is recommended to identify the most effective antibiotics against those isolates.
format Online
Article
Text
id pubmed-6004779
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60047792018-06-19 Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran Sadeqi Nezhad, M. Pordeli, H. Ghasemi, N. Ahani, A. New Microbes New Infect Original Article Siderophores secreted by nonfermentative negative bacilli such as Pseudomonas aeruginosa are capable of increasing rates of resistance to carbapenem antibiotics. Furthermore, the resistance of these isolates to antibiotics has been enhanced by producing siderophores, and their frequencies have erratic patterns. We studied the outbreak of P. aeruginosa strains and their antibiotic patterns in different clinical samples. In this descriptive cross-sectional study, 100 P. aeruginosa samples were isolated from different clinical specimens at the 5th Azar Hospital, Gorgan, Iran, in 2017. These strains were identified by biochemical tests, and their antibiotic resistance patterns were measured via the disc diffusion method. Next imipenem and EDTA-imipenem (10–30 μg) antibiotics were employed for the detection of siderophores. Amongst 100 P. aeruginosa samples, 31 isolates (31%) were siderophore carriers. The frequency of this enzyme among specimens was as follows: 56.2% in burn wounds, 36.4% in urine, 22.2% in respiratory secretion, 19.4% in blood and 16.7% in wounds (p > 0.05). Moreover, P. aeruginosa isolates producing siderophores had the highest range of resistance to ciprofloxacin (47.6%), gentamicin (46.7%), ceftazidime (34.9%), nalidixic acid (34.3%), amikacin (34.1%) and cefotaxime (31.6%). The prevalence of siderophore producers, and especially their antibiotic patterns have no specific algorithms; in addition, an antibiogram is recommended to identify the most effective antibiotics against those isolates. Elsevier 2018-04-21 /pmc/articles/PMC6004779/ /pubmed/29922475 http://dx.doi.org/10.1016/j.nmni.2018.04.003 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Sadeqi Nezhad, M.
Pordeli, H.
Ghasemi, N.
Ahani, A.
Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran
title Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran
title_full Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran
title_fullStr Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran
title_full_unstemmed Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran
title_short Evaluation of multidrug resistance patterns in siderophore-producing Pseudomonas aeruginosa from clinical and environmental samples in Gorgan, Iran
title_sort evaluation of multidrug resistance patterns in siderophore-producing pseudomonas aeruginosa from clinical and environmental samples in gorgan, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004779/
https://www.ncbi.nlm.nih.gov/pubmed/29922475
http://dx.doi.org/10.1016/j.nmni.2018.04.003
work_keys_str_mv AT sadeqinezhadm evaluationofmultidrugresistancepatternsinsiderophoreproducingpseudomonasaeruginosafromclinicalandenvironmentalsamplesingorganiran
AT pordelih evaluationofmultidrugresistancepatternsinsiderophoreproducingpseudomonasaeruginosafromclinicalandenvironmentalsamplesingorganiran
AT ghasemin evaluationofmultidrugresistancepatternsinsiderophoreproducingpseudomonasaeruginosafromclinicalandenvironmentalsamplesingorganiran
AT ahania evaluationofmultidrugresistancepatternsinsiderophoreproducingpseudomonasaeruginosafromclinicalandenvironmentalsamplesingorganiran